Global Anti-inflammatory Therapeutics Market 2026 by Company, Regions, Type and Application, Forecast to 2032
According to our (Global Info Research) latest study, the global Anti-inflammatory Therapeutics market size was valued at US$ 134950 million in 2025 and is forecast to a readjusted size of US$ 201440 million by 2032 with a CAGR of 6.0% during review period.
Anti-inflammatory therapeutics are treatments for arthritis, respiratory diseases, dermatology, psoriasis, inflammatory bowel disease and other inflammatory diseases. The treatments include anti-inflammatory biologics, NSAIDs, corticosteroids and others.
Top 5 manufacturers make up the major market share in the anti-inflammatory therapeutics market. AbbVie maintained its first place in the ranking in 2019, accounted for 21.59% market share. Other players accounted for 14.20%, 5.43%, 5.32% including Johnson & Johnson, Amgen Inc, AstraZeneca PLC.
This report is a detailed and comprehensive analysis for global Anti-inflammatory Therapeutics market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Anti-inflammatory Therapeutics market size and forecasts, in consumption value ($ Million), 2021-2032
Global Anti-inflammatory Therapeutics market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Anti-inflammatory Therapeutics market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Anti-inflammatory Therapeutics market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Anti-inflammatory Therapeutics
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Anti-inflammatory Therapeutics market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include AbbVie, Johnson & Johnson, Amgen Inc, AstraZeneca PLC, Pfizer, Inc, Novartis, Roche, Merck, Sanofi, GlaxoSmithKline, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Anti-inflammatory Therapeutics market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Anti-inflammatory Therapeutics product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Anti-inflammatory Therapeutics, with revenue, gross margin, and global market share of Anti-inflammatory Therapeutics from 2021 to 2026.
Chapter 3, the Anti-inflammatory Therapeutics competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Anti-inflammatory Therapeutics market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Anti-inflammatory Therapeutics.
Chapter 13, to describe Anti-inflammatory Therapeutics research findings and conclusion.
Anti-inflammatory therapeutics are treatments for arthritis, respiratory diseases, dermatology, psoriasis, inflammatory bowel disease and other inflammatory diseases. The treatments include anti-inflammatory biologics, NSAIDs, corticosteroids and others.
Top 5 manufacturers make up the major market share in the anti-inflammatory therapeutics market. AbbVie maintained its first place in the ranking in 2019, accounted for 21.59% market share. Other players accounted for 14.20%, 5.43%, 5.32% including Johnson & Johnson, Amgen Inc, AstraZeneca PLC.
This report is a detailed and comprehensive analysis for global Anti-inflammatory Therapeutics market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Anti-inflammatory Therapeutics market size and forecasts, in consumption value ($ Million), 2021-2032
Global Anti-inflammatory Therapeutics market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Anti-inflammatory Therapeutics market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Anti-inflammatory Therapeutics market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Anti-inflammatory Therapeutics
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Anti-inflammatory Therapeutics market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include AbbVie, Johnson & Johnson, Amgen Inc, AstraZeneca PLC, Pfizer, Inc, Novartis, Roche, Merck, Sanofi, GlaxoSmithKline, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Anti-inflammatory Therapeutics market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Anti-inflammatory Biologics
- Non-Steroidal Anti-inflammatory Drugs (NSAIDs)
- Corticosteroids
- Others
- Arthritis
- Respiratory Diseases
- Dermatology
- Gastroenterology
- Others
- AbbVie
- Johnson & Johnson
- Amgen Inc
- AstraZeneca PLC
- Pfizer, Inc
- Novartis
- Roche
- Merck
- Sanofi
- GlaxoSmithKline
- Sun Pharmaceutical Industries Ltd
- TEVA
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Anti-inflammatory Therapeutics product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Anti-inflammatory Therapeutics, with revenue, gross margin, and global market share of Anti-inflammatory Therapeutics from 2021 to 2026.
Chapter 3, the Anti-inflammatory Therapeutics competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Anti-inflammatory Therapeutics market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Anti-inflammatory Therapeutics.
Chapter 13, to describe Anti-inflammatory Therapeutics research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Anti-inflammatory Therapeutics by Type
1.3.1 Overview: Global Anti-inflammatory Therapeutics Market Size by Type: 2021 Versus 2025 Versus 2032
1.3.2 Global Anti-inflammatory Therapeutics Consumption Value Market Share by Type in 2025
1.3.3 Anti-inflammatory Biologics
1.3.4 Non-Steroidal Anti-inflammatory Drugs (NSAIDs)
1.3.5 Corticosteroids
1.3.6 Others
1.4 Global Anti-inflammatory Therapeutics Market by Application
1.4.1 Overview: Global Anti-inflammatory Therapeutics Market Size by Application: 2021 Versus 2025 Versus 2032
1.4.2 Arthritis
1.4.3 Respiratory Diseases
1.4.4 Dermatology
1.4.5 Gastroenterology
1.4.6 Others
1.5 Global Anti-inflammatory Therapeutics Market Size & Forecast
1.6 Global Anti-inflammatory Therapeutics Market Size and Forecast by Region
1.6.1 Global Anti-inflammatory Therapeutics Market Size by Region: 2021 VS 2025 VS 2032
1.6.2 Global Anti-inflammatory Therapeutics Market Size by Region, (2021-2032)
1.6.3 North America Anti-inflammatory Therapeutics Market Size and Prospect (2021-2032)
1.6.4 Europe Anti-inflammatory Therapeutics Market Size and Prospect (2021-2032)
1.6.5 Asia-Pacific Anti-inflammatory Therapeutics Market Size and Prospect (2021-2032)
1.6.6 South America Anti-inflammatory Therapeutics Market Size and Prospect (2021-2032)
1.6.7 Middle East & Africa Anti-inflammatory Therapeutics Market Size and Prospect (2021-2032)
2 COMPANY PROFILES
2.1 AbbVie
2.1.1 AbbVie Details
2.1.2 AbbVie Major Business
2.1.3 AbbVie Anti-inflammatory Therapeutics Product and Solutions
2.1.4 AbbVie Anti-inflammatory Therapeutics Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 AbbVie Recent Developments and Future Plans
2.2 Johnson & Johnson
2.2.1 Johnson & Johnson Details
2.2.2 Johnson & Johnson Major Business
2.2.3 Johnson & Johnson Anti-inflammatory Therapeutics Product and Solutions
2.2.4 Johnson & Johnson Anti-inflammatory Therapeutics Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 Johnson & Johnson Recent Developments and Future Plans
2.3 Amgen Inc
2.3.1 Amgen Inc Details
2.3.2 Amgen Inc Major Business
2.3.3 Amgen Inc Anti-inflammatory Therapeutics Product and Solutions
2.3.4 Amgen Inc Anti-inflammatory Therapeutics Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 Amgen Inc Recent Developments and Future Plans
2.4 AstraZeneca PLC
2.4.1 AstraZeneca PLC Details
2.4.2 AstraZeneca PLC Major Business
2.4.3 AstraZeneca PLC Anti-inflammatory Therapeutics Product and Solutions
2.4.4 AstraZeneca PLC Anti-inflammatory Therapeutics Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 AstraZeneca PLC Recent Developments and Future Plans
2.5 Pfizer, Inc
2.5.1 Pfizer, Inc Details
2.5.2 Pfizer, Inc Major Business
2.5.3 Pfizer, Inc Anti-inflammatory Therapeutics Product and Solutions
2.5.4 Pfizer, Inc Anti-inflammatory Therapeutics Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 Pfizer, Inc Recent Developments and Future Plans
2.6 Novartis
2.6.1 Novartis Details
2.6.2 Novartis Major Business
2.6.3 Novartis Anti-inflammatory Therapeutics Product and Solutions
2.6.4 Novartis Anti-inflammatory Therapeutics Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 Novartis Recent Developments and Future Plans
2.7 Roche
2.7.1 Roche Details
2.7.2 Roche Major Business
2.7.3 Roche Anti-inflammatory Therapeutics Product and Solutions
2.7.4 Roche Anti-inflammatory Therapeutics Revenue, Gross Margin and Market Share (2021-2026)
2.7.5 Roche Recent Developments and Future Plans
2.8 Merck
2.8.1 Merck Details
2.8.2 Merck Major Business
2.8.3 Merck Anti-inflammatory Therapeutics Product and Solutions
2.8.4 Merck Anti-inflammatory Therapeutics Revenue, Gross Margin and Market Share (2021-2026)
2.8.5 Merck Recent Developments and Future Plans
2.9 Sanofi
2.9.1 Sanofi Details
2.9.2 Sanofi Major Business
2.9.3 Sanofi Anti-inflammatory Therapeutics Product and Solutions
2.9.4 Sanofi Anti-inflammatory Therapeutics Revenue, Gross Margin and Market Share (2021-2026)
2.9.5 Sanofi Recent Developments and Future Plans
2.10 GlaxoSmithKline
2.10.1 GlaxoSmithKline Details
2.10.2 GlaxoSmithKline Major Business
2.10.3 GlaxoSmithKline Anti-inflammatory Therapeutics Product and Solutions
2.10.4 GlaxoSmithKline Anti-inflammatory Therapeutics Revenue, Gross Margin and Market Share (2021-2026)
2.10.5 GlaxoSmithKline Recent Developments and Future Plans
2.11 Sun Pharmaceutical Industries Ltd
2.11.1 Sun Pharmaceutical Industries Ltd Details
2.11.2 Sun Pharmaceutical Industries Ltd Major Business
2.11.3 Sun Pharmaceutical Industries Ltd Anti-inflammatory Therapeutics Product and Solutions
2.11.4 Sun Pharmaceutical Industries Ltd Anti-inflammatory Therapeutics Revenue, Gross Margin and Market Share (2021-2026)
2.11.5 Sun Pharmaceutical Industries Ltd Recent Developments and Future Plans
2.12 TEVA
2.12.1 TEVA Details
2.12.2 TEVA Major Business
2.12.3 TEVA Anti-inflammatory Therapeutics Product and Solutions
2.12.4 TEVA Anti-inflammatory Therapeutics Revenue, Gross Margin and Market Share (2021-2026)
2.12.5 TEVA Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Anti-inflammatory Therapeutics Revenue and Share by Players (2021-2026)
3.2 Market Share Analysis (2025)
3.2.1 Market Share of Anti-inflammatory Therapeutics by Company Revenue
3.2.2 Top 3 Anti-inflammatory Therapeutics Players Market Share in 2025
3.2.3 Top 6 Anti-inflammatory Therapeutics Players Market Share in 2025
3.3 Anti-inflammatory Therapeutics Market: Overall Company Footprint Analysis
3.3.1 Anti-inflammatory Therapeutics Market: Region Footprint
3.3.2 Anti-inflammatory Therapeutics Market: Company Product Type Footprint
3.3.3 Anti-inflammatory Therapeutics Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Anti-inflammatory Therapeutics Consumption Value and Market Share by Type (2021-2026)
4.2 Global Anti-inflammatory Therapeutics Market Forecast by Type (2027-2032)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Anti-inflammatory Therapeutics Consumption Value Market Share by Application (2021-2026)
5.2 Global Anti-inflammatory Therapeutics Market Forecast by Application (2027-2032)
6 NORTH AMERICA
6.1 North America Anti-inflammatory Therapeutics Consumption Value by Type (2021-2032)
6.2 North America Anti-inflammatory Therapeutics Market Size by Application (2021-2032)
6.3 North America Anti-inflammatory Therapeutics Market Size by Country
6.3.1 North America Anti-inflammatory Therapeutics Consumption Value by Country (2021-2032)
6.3.2 United States Anti-inflammatory Therapeutics Market Size and Forecast (2021-2032)
6.3.3 Canada Anti-inflammatory Therapeutics Market Size and Forecast (2021-2032)
6.3.4 Mexico Anti-inflammatory Therapeutics Market Size and Forecast (2021-2032)
7 EUROPE
7.1 Europe Anti-inflammatory Therapeutics Consumption Value by Type (2021-2032)
7.2 Europe Anti-inflammatory Therapeutics Consumption Value by Application (2021-2032)
7.3 Europe Anti-inflammatory Therapeutics Market Size by Country
7.3.1 Europe Anti-inflammatory Therapeutics Consumption Value by Country (2021-2032)
7.3.2 Germany Anti-inflammatory Therapeutics Market Size and Forecast (2021-2032)
7.3.3 France Anti-inflammatory Therapeutics Market Size and Forecast (2021-2032)
7.3.4 United Kingdom Anti-inflammatory Therapeutics Market Size and Forecast (2021-2032)
7.3.5 Russia Anti-inflammatory Therapeutics Market Size and Forecast (2021-2032)
7.3.6 Italy Anti-inflammatory Therapeutics Market Size and Forecast (2021-2032)
8 ASIA-PACIFIC
8.1 Asia-Pacific Anti-inflammatory Therapeutics Consumption Value by Type (2021-2032)
8.2 Asia-Pacific Anti-inflammatory Therapeutics Consumption Value by Application (2021-2032)
8.3 Asia-Pacific Anti-inflammatory Therapeutics Market Size by Region
8.3.1 Asia-Pacific Anti-inflammatory Therapeutics Consumption Value by Region (2021-2032)
8.3.2 China Anti-inflammatory Therapeutics Market Size and Forecast (2021-2032)
8.3.3 Japan Anti-inflammatory Therapeutics Market Size and Forecast (2021-2032)
8.3.4 South Korea Anti-inflammatory Therapeutics Market Size and Forecast (2021-2032)
8.3.5 India Anti-inflammatory Therapeutics Market Size and Forecast (2021-2032)
8.3.6 Southeast Asia Anti-inflammatory Therapeutics Market Size and Forecast (2021-2032)
8.3.7 Australia Anti-inflammatory Therapeutics Market Size and Forecast (2021-2032)
9 SOUTH AMERICA
9.1 South America Anti-inflammatory Therapeutics Consumption Value by Type (2021-2032)
9.2 South America Anti-inflammatory Therapeutics Consumption Value by Application (2021-2032)
9.3 South America Anti-inflammatory Therapeutics Market Size by Country
9.3.1 South America Anti-inflammatory Therapeutics Consumption Value by Country (2021-2032)
9.3.2 Brazil Anti-inflammatory Therapeutics Market Size and Forecast (2021-2032)
9.3.3 Argentina Anti-inflammatory Therapeutics Market Size and Forecast (2021-2032)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Anti-inflammatory Therapeutics Consumption Value by Type (2021-2032)
10.2 Middle East & Africa Anti-inflammatory Therapeutics Consumption Value by Application (2021-2032)
10.3 Middle East & Africa Anti-inflammatory Therapeutics Market Size by Country
10.3.1 Middle East & Africa Anti-inflammatory Therapeutics Consumption Value by Country (2021-2032)
10.3.2 Turkey Anti-inflammatory Therapeutics Market Size and Forecast (2021-2032)
10.3.3 Saudi Arabia Anti-inflammatory Therapeutics Market Size and Forecast (2021-2032)
10.3.4 UAE Anti-inflammatory Therapeutics Market Size and Forecast (2021-2032)
11 MARKET DYNAMICS
11.1 Anti-inflammatory Therapeutics Market Drivers
11.2 Anti-inflammatory Therapeutics Market Restraints
11.3 Anti-inflammatory Therapeutics Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Anti-inflammatory Therapeutics Industry Chain
12.2 Anti-inflammatory Therapeutics Upstream Analysis
12.3 Anti-inflammatory Therapeutics Midstream Analysis
12.4 Anti-inflammatory Therapeutics Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Anti-inflammatory Therapeutics by Type
1.3.1 Overview: Global Anti-inflammatory Therapeutics Market Size by Type: 2021 Versus 2025 Versus 2032
1.3.2 Global Anti-inflammatory Therapeutics Consumption Value Market Share by Type in 2025
1.3.3 Anti-inflammatory Biologics
1.3.4 Non-Steroidal Anti-inflammatory Drugs (NSAIDs)
1.3.5 Corticosteroids
1.3.6 Others
1.4 Global Anti-inflammatory Therapeutics Market by Application
1.4.1 Overview: Global Anti-inflammatory Therapeutics Market Size by Application: 2021 Versus 2025 Versus 2032
1.4.2 Arthritis
1.4.3 Respiratory Diseases
1.4.4 Dermatology
1.4.5 Gastroenterology
1.4.6 Others
1.5 Global Anti-inflammatory Therapeutics Market Size & Forecast
1.6 Global Anti-inflammatory Therapeutics Market Size and Forecast by Region
1.6.1 Global Anti-inflammatory Therapeutics Market Size by Region: 2021 VS 2025 VS 2032
1.6.2 Global Anti-inflammatory Therapeutics Market Size by Region, (2021-2032)
1.6.3 North America Anti-inflammatory Therapeutics Market Size and Prospect (2021-2032)
1.6.4 Europe Anti-inflammatory Therapeutics Market Size and Prospect (2021-2032)
1.6.5 Asia-Pacific Anti-inflammatory Therapeutics Market Size and Prospect (2021-2032)
1.6.6 South America Anti-inflammatory Therapeutics Market Size and Prospect (2021-2032)
1.6.7 Middle East & Africa Anti-inflammatory Therapeutics Market Size and Prospect (2021-2032)
2 COMPANY PROFILES
2.1 AbbVie
2.1.1 AbbVie Details
2.1.2 AbbVie Major Business
2.1.3 AbbVie Anti-inflammatory Therapeutics Product and Solutions
2.1.4 AbbVie Anti-inflammatory Therapeutics Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 AbbVie Recent Developments and Future Plans
2.2 Johnson & Johnson
2.2.1 Johnson & Johnson Details
2.2.2 Johnson & Johnson Major Business
2.2.3 Johnson & Johnson Anti-inflammatory Therapeutics Product and Solutions
2.2.4 Johnson & Johnson Anti-inflammatory Therapeutics Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 Johnson & Johnson Recent Developments and Future Plans
2.3 Amgen Inc
2.3.1 Amgen Inc Details
2.3.2 Amgen Inc Major Business
2.3.3 Amgen Inc Anti-inflammatory Therapeutics Product and Solutions
2.3.4 Amgen Inc Anti-inflammatory Therapeutics Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 Amgen Inc Recent Developments and Future Plans
2.4 AstraZeneca PLC
2.4.1 AstraZeneca PLC Details
2.4.2 AstraZeneca PLC Major Business
2.4.3 AstraZeneca PLC Anti-inflammatory Therapeutics Product and Solutions
2.4.4 AstraZeneca PLC Anti-inflammatory Therapeutics Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 AstraZeneca PLC Recent Developments and Future Plans
2.5 Pfizer, Inc
2.5.1 Pfizer, Inc Details
2.5.2 Pfizer, Inc Major Business
2.5.3 Pfizer, Inc Anti-inflammatory Therapeutics Product and Solutions
2.5.4 Pfizer, Inc Anti-inflammatory Therapeutics Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 Pfizer, Inc Recent Developments and Future Plans
2.6 Novartis
2.6.1 Novartis Details
2.6.2 Novartis Major Business
2.6.3 Novartis Anti-inflammatory Therapeutics Product and Solutions
2.6.4 Novartis Anti-inflammatory Therapeutics Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 Novartis Recent Developments and Future Plans
2.7 Roche
2.7.1 Roche Details
2.7.2 Roche Major Business
2.7.3 Roche Anti-inflammatory Therapeutics Product and Solutions
2.7.4 Roche Anti-inflammatory Therapeutics Revenue, Gross Margin and Market Share (2021-2026)
2.7.5 Roche Recent Developments and Future Plans
2.8 Merck
2.8.1 Merck Details
2.8.2 Merck Major Business
2.8.3 Merck Anti-inflammatory Therapeutics Product and Solutions
2.8.4 Merck Anti-inflammatory Therapeutics Revenue, Gross Margin and Market Share (2021-2026)
2.8.5 Merck Recent Developments and Future Plans
2.9 Sanofi
2.9.1 Sanofi Details
2.9.2 Sanofi Major Business
2.9.3 Sanofi Anti-inflammatory Therapeutics Product and Solutions
2.9.4 Sanofi Anti-inflammatory Therapeutics Revenue, Gross Margin and Market Share (2021-2026)
2.9.5 Sanofi Recent Developments and Future Plans
2.10 GlaxoSmithKline
2.10.1 GlaxoSmithKline Details
2.10.2 GlaxoSmithKline Major Business
2.10.3 GlaxoSmithKline Anti-inflammatory Therapeutics Product and Solutions
2.10.4 GlaxoSmithKline Anti-inflammatory Therapeutics Revenue, Gross Margin and Market Share (2021-2026)
2.10.5 GlaxoSmithKline Recent Developments and Future Plans
2.11 Sun Pharmaceutical Industries Ltd
2.11.1 Sun Pharmaceutical Industries Ltd Details
2.11.2 Sun Pharmaceutical Industries Ltd Major Business
2.11.3 Sun Pharmaceutical Industries Ltd Anti-inflammatory Therapeutics Product and Solutions
2.11.4 Sun Pharmaceutical Industries Ltd Anti-inflammatory Therapeutics Revenue, Gross Margin and Market Share (2021-2026)
2.11.5 Sun Pharmaceutical Industries Ltd Recent Developments and Future Plans
2.12 TEVA
2.12.1 TEVA Details
2.12.2 TEVA Major Business
2.12.3 TEVA Anti-inflammatory Therapeutics Product and Solutions
2.12.4 TEVA Anti-inflammatory Therapeutics Revenue, Gross Margin and Market Share (2021-2026)
2.12.5 TEVA Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Anti-inflammatory Therapeutics Revenue and Share by Players (2021-2026)
3.2 Market Share Analysis (2025)
3.2.1 Market Share of Anti-inflammatory Therapeutics by Company Revenue
3.2.2 Top 3 Anti-inflammatory Therapeutics Players Market Share in 2025
3.2.3 Top 6 Anti-inflammatory Therapeutics Players Market Share in 2025
3.3 Anti-inflammatory Therapeutics Market: Overall Company Footprint Analysis
3.3.1 Anti-inflammatory Therapeutics Market: Region Footprint
3.3.2 Anti-inflammatory Therapeutics Market: Company Product Type Footprint
3.3.3 Anti-inflammatory Therapeutics Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Anti-inflammatory Therapeutics Consumption Value and Market Share by Type (2021-2026)
4.2 Global Anti-inflammatory Therapeutics Market Forecast by Type (2027-2032)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Anti-inflammatory Therapeutics Consumption Value Market Share by Application (2021-2026)
5.2 Global Anti-inflammatory Therapeutics Market Forecast by Application (2027-2032)
6 NORTH AMERICA
6.1 North America Anti-inflammatory Therapeutics Consumption Value by Type (2021-2032)
6.2 North America Anti-inflammatory Therapeutics Market Size by Application (2021-2032)
6.3 North America Anti-inflammatory Therapeutics Market Size by Country
6.3.1 North America Anti-inflammatory Therapeutics Consumption Value by Country (2021-2032)
6.3.2 United States Anti-inflammatory Therapeutics Market Size and Forecast (2021-2032)
6.3.3 Canada Anti-inflammatory Therapeutics Market Size and Forecast (2021-2032)
6.3.4 Mexico Anti-inflammatory Therapeutics Market Size and Forecast (2021-2032)
7 EUROPE
7.1 Europe Anti-inflammatory Therapeutics Consumption Value by Type (2021-2032)
7.2 Europe Anti-inflammatory Therapeutics Consumption Value by Application (2021-2032)
7.3 Europe Anti-inflammatory Therapeutics Market Size by Country
7.3.1 Europe Anti-inflammatory Therapeutics Consumption Value by Country (2021-2032)
7.3.2 Germany Anti-inflammatory Therapeutics Market Size and Forecast (2021-2032)
7.3.3 France Anti-inflammatory Therapeutics Market Size and Forecast (2021-2032)
7.3.4 United Kingdom Anti-inflammatory Therapeutics Market Size and Forecast (2021-2032)
7.3.5 Russia Anti-inflammatory Therapeutics Market Size and Forecast (2021-2032)
7.3.6 Italy Anti-inflammatory Therapeutics Market Size and Forecast (2021-2032)
8 ASIA-PACIFIC
8.1 Asia-Pacific Anti-inflammatory Therapeutics Consumption Value by Type (2021-2032)
8.2 Asia-Pacific Anti-inflammatory Therapeutics Consumption Value by Application (2021-2032)
8.3 Asia-Pacific Anti-inflammatory Therapeutics Market Size by Region
8.3.1 Asia-Pacific Anti-inflammatory Therapeutics Consumption Value by Region (2021-2032)
8.3.2 China Anti-inflammatory Therapeutics Market Size and Forecast (2021-2032)
8.3.3 Japan Anti-inflammatory Therapeutics Market Size and Forecast (2021-2032)
8.3.4 South Korea Anti-inflammatory Therapeutics Market Size and Forecast (2021-2032)
8.3.5 India Anti-inflammatory Therapeutics Market Size and Forecast (2021-2032)
8.3.6 Southeast Asia Anti-inflammatory Therapeutics Market Size and Forecast (2021-2032)
8.3.7 Australia Anti-inflammatory Therapeutics Market Size and Forecast (2021-2032)
9 SOUTH AMERICA
9.1 South America Anti-inflammatory Therapeutics Consumption Value by Type (2021-2032)
9.2 South America Anti-inflammatory Therapeutics Consumption Value by Application (2021-2032)
9.3 South America Anti-inflammatory Therapeutics Market Size by Country
9.3.1 South America Anti-inflammatory Therapeutics Consumption Value by Country (2021-2032)
9.3.2 Brazil Anti-inflammatory Therapeutics Market Size and Forecast (2021-2032)
9.3.3 Argentina Anti-inflammatory Therapeutics Market Size and Forecast (2021-2032)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Anti-inflammatory Therapeutics Consumption Value by Type (2021-2032)
10.2 Middle East & Africa Anti-inflammatory Therapeutics Consumption Value by Application (2021-2032)
10.3 Middle East & Africa Anti-inflammatory Therapeutics Market Size by Country
10.3.1 Middle East & Africa Anti-inflammatory Therapeutics Consumption Value by Country (2021-2032)
10.3.2 Turkey Anti-inflammatory Therapeutics Market Size and Forecast (2021-2032)
10.3.3 Saudi Arabia Anti-inflammatory Therapeutics Market Size and Forecast (2021-2032)
10.3.4 UAE Anti-inflammatory Therapeutics Market Size and Forecast (2021-2032)
11 MARKET DYNAMICS
11.1 Anti-inflammatory Therapeutics Market Drivers
11.2 Anti-inflammatory Therapeutics Market Restraints
11.3 Anti-inflammatory Therapeutics Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Anti-inflammatory Therapeutics Industry Chain
12.2 Anti-inflammatory Therapeutics Upstream Analysis
12.3 Anti-inflammatory Therapeutics Midstream Analysis
12.4 Anti-inflammatory Therapeutics Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF FIGURES
Table 1. Global Anti-inflammatory Therapeutics Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global Anti-inflammatory Therapeutics Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 3. Global Anti-inflammatory Therapeutics Consumption Value by Region (2021-2026) & (USD Million)
Table 4. Global Anti-inflammatory Therapeutics Consumption Value by Region (2027-2032) & (USD Million)
Table 5. AbbVie Company Information, Head Office, and Major Competitors
Table 6. AbbVie Major Business
Table 7. AbbVie Anti-inflammatory Therapeutics Product and Solutions
Table 8. AbbVie Anti-inflammatory Therapeutics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 9. AbbVie Recent Developments and Future Plans
Table 10. Johnson & Johnson Company Information, Head Office, and Major Competitors
Table 11. Johnson & Johnson Major Business
Table 12. Johnson & Johnson Anti-inflammatory Therapeutics Product and Solutions
Table 13. Johnson & Johnson Anti-inflammatory Therapeutics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 14. Johnson & Johnson Recent Developments and Future Plans
Table 15. Amgen Inc Company Information, Head Office, and Major Competitors
Table 16. Amgen Inc Major Business
Table 17. Amgen Inc Anti-inflammatory Therapeutics Product and Solutions
Table 18. Amgen Inc Anti-inflammatory Therapeutics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 19. AstraZeneca PLC Company Information, Head Office, and Major Competitors
Table 20. AstraZeneca PLC Major Business
Table 21. AstraZeneca PLC Anti-inflammatory Therapeutics Product and Solutions
Table 22. AstraZeneca PLC Anti-inflammatory Therapeutics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 23. AstraZeneca PLC Recent Developments and Future Plans
Table 24. Pfizer, Inc Company Information, Head Office, and Major Competitors
Table 25. Pfizer, Inc Major Business
Table 26. Pfizer, Inc Anti-inflammatory Therapeutics Product and Solutions
Table 27. Pfizer, Inc Anti-inflammatory Therapeutics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 28. Pfizer, Inc Recent Developments and Future Plans
Table 29. Novartis Company Information, Head Office, and Major Competitors
Table 30. Novartis Major Business
Table 31. Novartis Anti-inflammatory Therapeutics Product and Solutions
Table 32. Novartis Anti-inflammatory Therapeutics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 33. Novartis Recent Developments and Future Plans
Table 34. Roche Company Information, Head Office, and Major Competitors
Table 35. Roche Major Business
Table 36. Roche Anti-inflammatory Therapeutics Product and Solutions
Table 37. Roche Anti-inflammatory Therapeutics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 38. Roche Recent Developments and Future Plans
Table 39. Merck Company Information, Head Office, and Major Competitors
Table 40. Merck Major Business
Table 41. Merck Anti-inflammatory Therapeutics Product and Solutions
Table 42. Merck Anti-inflammatory Therapeutics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 43. Merck Recent Developments and Future Plans
Table 44. Sanofi Company Information, Head Office, and Major Competitors
Table 45. Sanofi Major Business
Table 46. Sanofi Anti-inflammatory Therapeutics Product and Solutions
Table 47. Sanofi Anti-inflammatory Therapeutics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 48. Sanofi Recent Developments and Future Plans
Table 49. GlaxoSmithKline Company Information, Head Office, and Major Competitors
Table 50. GlaxoSmithKline Major Business
Table 51. GlaxoSmithKline Anti-inflammatory Therapeutics Product and Solutions
Table 52. GlaxoSmithKline Anti-inflammatory Therapeutics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 53. GlaxoSmithKline Recent Developments and Future Plans
Table 54. Sun Pharmaceutical Industries Ltd Company Information, Head Office, and Major Competitors
Table 55. Sun Pharmaceutical Industries Ltd Major Business
Table 56. Sun Pharmaceutical Industries Ltd Anti-inflammatory Therapeutics Product and Solutions
Table 57. Sun Pharmaceutical Industries Ltd Anti-inflammatory Therapeutics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 58. Sun Pharmaceutical Industries Ltd Recent Developments and Future Plans
Table 59. TEVA Company Information, Head Office, and Major Competitors
Table 60. TEVA Major Business
Table 61. TEVA Anti-inflammatory Therapeutics Product and Solutions
Table 62. TEVA Anti-inflammatory Therapeutics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 63. TEVA Recent Developments and Future Plans
Table 64. Global Anti-inflammatory Therapeutics Revenue (USD Million) by Players (2021-2026)
Table 65. Global Anti-inflammatory Therapeutics Revenue Share by Players (2021-2026)
Table 66. Breakdown of Anti-inflammatory Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3)
Table 67. Market Position of Players in Anti-inflammatory Therapeutics, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 68. Head Office of Key Anti-inflammatory Therapeutics Players
Table 69. Anti-inflammatory Therapeutics Market: Company Product Type Footprint
Table 70. Anti-inflammatory Therapeutics Market: Company Product Application Footprint
Table 71. Anti-inflammatory Therapeutics New Market Entrants and Barriers to Market Entry
Table 72. Anti-inflammatory Therapeutics Mergers, Acquisition, Agreements, and Collaborations
Table 73. Global Anti-inflammatory Therapeutics Consumption Value (USD Million) by Type (2021-2026)
Table 74. Global Anti-inflammatory Therapeutics Consumption Value Share by Type (2021-2026)
Table 75. Global Anti-inflammatory Therapeutics Consumption Value Forecast by Type (2027-2032)
Table 76. Global Anti-inflammatory Therapeutics Consumption Value by Application (2021-2026)
Table 77. Global Anti-inflammatory Therapeutics Consumption Value Forecast by Application (2027-2032)
Table 78. North America Anti-inflammatory Therapeutics Consumption Value by Type (2021-2026) & (USD Million)
Table 79. North America Anti-inflammatory Therapeutics Consumption Value by Type (2027-2032) & (USD Million)
Table 80. North America Anti-inflammatory Therapeutics Consumption Value by Application (2021-2026) & (USD Million)
Table 81. North America Anti-inflammatory Therapeutics Consumption Value by Application (2027-2032) & (USD Million)
Table 82. North America Anti-inflammatory Therapeutics Consumption Value by Country (2021-2026) & (USD Million)
Table 83. North America Anti-inflammatory Therapeutics Consumption Value by Country (2027-2032) & (USD Million)
Table 84. Europe Anti-inflammatory Therapeutics Consumption Value by Type (2021-2026) & (USD Million)
Table 85. Europe Anti-inflammatory Therapeutics Consumption Value by Type (2027-2032) & (USD Million)
Table 86. Europe Anti-inflammatory Therapeutics Consumption Value by Application (2021-2026) & (USD Million)
Table 87. Europe Anti-inflammatory Therapeutics Consumption Value by Application (2027-2032) & (USD Million)
Table 88. Europe Anti-inflammatory Therapeutics Consumption Value by Country (2021-2026) & (USD Million)
Table 89. Europe Anti-inflammatory Therapeutics Consumption Value by Country (2027-2032) & (USD Million)
Table 90. Asia-Pacific Anti-inflammatory Therapeutics Consumption Value by Type (2021-2026) & (USD Million)
Table 91. Asia-Pacific Anti-inflammatory Therapeutics Consumption Value by Type (2027-2032) & (USD Million)
Table 92. Asia-Pacific Anti-inflammatory Therapeutics Consumption Value by Application (2021-2026) & (USD Million)
Table 93. Asia-Pacific Anti-inflammatory Therapeutics Consumption Value by Application (2027-2032) & (USD Million)
Table 94. Asia-Pacific Anti-inflammatory Therapeutics Consumption Value by Region (2021-2026) & (USD Million)
Table 95. Asia-Pacific Anti-inflammatory Therapeutics Consumption Value by Region (2027-2032) & (USD Million)
Table 96. South America Anti-inflammatory Therapeutics Consumption Value by Type (2021-2026) & (USD Million)
Table 97. South America Anti-inflammatory Therapeutics Consumption Value by Type (2027-2032) & (USD Million)
Table 98. South America Anti-inflammatory Therapeutics Consumption Value by Application (2021-2026) & (USD Million)
Table 99. South America Anti-inflammatory Therapeutics Consumption Value by Application (2027-2032) & (USD Million)
Table 100. South America Anti-inflammatory Therapeutics Consumption Value by Country (2021-2026) & (USD Million)
Table 101. South America Anti-inflammatory Therapeutics Consumption Value by Country (2027-2032) & (USD Million)
Table 102. Middle East & Africa Anti-inflammatory Therapeutics Consumption Value by Type (2021-2026) & (USD Million)
Table 103. Middle East & Africa Anti-inflammatory Therapeutics Consumption Value by Type (2027-2032) & (USD Million)
Table 104. Middle East & Africa Anti-inflammatory Therapeutics Consumption Value by Application (2021-2026) & (USD Million)
Table 105. Middle East & Africa Anti-inflammatory Therapeutics Consumption Value by Application (2027-2032) & (USD Million)
Table 106. Middle East & Africa Anti-inflammatory Therapeutics Consumption Value by Country (2021-2026) & (USD Million)
Table 107. Middle East & Africa Anti-inflammatory Therapeutics Consumption Value by Country (2027-2032) & (USD Million)
Table 108. Global Key Players of Anti-inflammatory Therapeutics Upstream (Raw Materials)
Table 109. Global Anti-inflammatory Therapeutics Typical Customers
LIST OF FIGURES
Figure 1. Anti-inflammatory Therapeutics Picture
Figure 2. Global Anti-inflammatory Therapeutics Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global Anti-inflammatory Therapeutics Consumption Value Market Share by Type in 2025
Figure 4. Anti-inflammatory Biologics
Figure 5. Non-Steroidal Anti-inflammatory Drugs (NSAIDs)
Figure 6. Corticosteroids
Figure 7. Others
Figure 8. Global Anti-inflammatory Therapeutics Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 9. Anti-inflammatory Therapeutics Consumption Value Market Share by Application in 2025
Figure 10. Arthritis Picture
Figure 11. Respiratory Diseases Picture
Figure 12. Dermatology Picture
Figure 13. Gastroenterology Picture
Figure 14. Others Picture
Figure 15. Global Anti-inflammatory Therapeutics Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 16. Global Anti-inflammatory Therapeutics Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 17. Global Market Anti-inflammatory Therapeutics Consumption Value (USD Million) Comparison by Region (2021 VS 2025 VS 2032)
Figure 18. Global Anti-inflammatory Therapeutics Consumption Value Market Share by Region (2021-2032)
Figure 19. Global Anti-inflammatory Therapeutics Consumption Value Market Share by Region in 2025
Figure 20. North America Anti-inflammatory Therapeutics Consumption Value (2021-2032) & (USD Million)
Figure 21. Europe Anti-inflammatory Therapeutics Consumption Value (2021-2032) & (USD Million)
Figure 22. Asia-Pacific Anti-inflammatory Therapeutics Consumption Value (2021-2032) & (USD Million)
Figure 23. South America Anti-inflammatory Therapeutics Consumption Value (2021-2032) & (USD Million)
Figure 24. Middle East & Africa Anti-inflammatory Therapeutics Consumption Value (2021-2032) & (USD Million)
Figure 25. Company Three Recent Developments and Future Plans
Figure 26. Global Anti-inflammatory Therapeutics Revenue Share by Players in 2025
Figure 27. Anti-inflammatory Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2025
Figure 28. Market Share of Anti-inflammatory Therapeutics by Player Revenue in 2025
Figure 29. Top 3 Anti-inflammatory Therapeutics Players Market Share in 2025
Figure 30. Top 6 Anti-inflammatory Therapeutics Players Market Share in 2025
Figure 31. Global Anti-inflammatory Therapeutics Consumption Value Share by Type (2021-2026)
Figure 32. Global Anti-inflammatory Therapeutics Market Share Forecast by Type (2027-2032)
Figure 33. Global Anti-inflammatory Therapeutics Consumption Value Share by Application (2021-2026)
Figure 34. Global Anti-inflammatory Therapeutics Market Share Forecast by Application (2027-2032)
Figure 35. North America Anti-inflammatory Therapeutics Consumption Value Market Share by Type (2021-2032)
Figure 36. North America Anti-inflammatory Therapeutics Consumption Value Market Share by Application (2021-2032)
Figure 37. North America Anti-inflammatory Therapeutics Consumption Value Market Share by Country (2021-2032)
Figure 38. United States Anti-inflammatory Therapeutics Consumption Value (2021-2032) & (USD Million)
Figure 39. Canada Anti-inflammatory Therapeutics Consumption Value (2021-2032) & (USD Million)
Figure 40. Mexico Anti-inflammatory Therapeutics Consumption Value (2021-2032) & (USD Million)
Figure 41. Europe Anti-inflammatory Therapeutics Consumption Value Market Share by Type (2021-2032)
Figure 42. Europe Anti-inflammatory Therapeutics Consumption Value Market Share by Application (2021-2032)
Figure 43. Europe Anti-inflammatory Therapeutics Consumption Value Market Share by Country (2021-2032)
Figure 44. Germany Anti-inflammatory Therapeutics Consumption Value (2021-2032) & (USD Million)
Figure 45. France Anti-inflammatory Therapeutics Consumption Value (2021-2032) & (USD Million)
Figure 46. United Kingdom Anti-inflammatory Therapeutics Consumption Value (2021-2032) & (USD Million)
Figure 47. Russia Anti-inflammatory Therapeutics Consumption Value (2021-2032) & (USD Million)
Figure 48. Italy Anti-inflammatory Therapeutics Consumption Value (2021-2032) & (USD Million)
Figure 49. Asia-Pacific Anti-inflammatory Therapeutics Consumption Value Market Share by Type (2021-2032)
Figure 50. Asia-Pacific Anti-inflammatory Therapeutics Consumption Value Market Share by Application (2021-2032)
Figure 51. Asia-Pacific Anti-inflammatory Therapeutics Consumption Value Market Share by Region (2021-2032)
Figure 52. China Anti-inflammatory Therapeutics Consumption Value (2021-2032) & (USD Million)
Figure 53. Japan Anti-inflammatory Therapeutics Consumption Value (2021-2032) & (USD Million)
Figure 54. South Korea Anti-inflammatory Therapeutics Consumption Value (2021-2032) & (USD Million)
Figure 55. India Anti-inflammatory Therapeutics Consumption Value (2021-2032) & (USD Million)
Figure 56. Southeast Asia Anti-inflammatory Therapeutics Consumption Value (2021-2032) & (USD Million)
Figure 57. Australia Anti-inflammatory Therapeutics Consumption Value (2021-2032) & (USD Million)
Figure 58. South America Anti-inflammatory Therapeutics Consumption Value Market Share by Type (2021-2032)
Figure 59. South America Anti-inflammatory Therapeutics Consumption Value Market Share by Application (2021-2032)
Figure 60. South America Anti-inflammatory Therapeutics Consumption Value Market Share by Country (2021-2032)
Figure 61. Brazil Anti-inflammatory Therapeutics Consumption Value (2021-2032) & (USD Million)
Figure 62. Argentina Anti-inflammatory Therapeutics Consumption Value (2021-2032) & (USD Million)
Figure 63. Middle East & Africa Anti-inflammatory Therapeutics Consumption Value Market Share by Type (2021-2032)
Figure 64. Middle East & Africa Anti-inflammatory Therapeutics Consumption Value Market Share by Application (2021-2032)
Figure 65. Middle East & Africa Anti-inflammatory Therapeutics Consumption Value Market Share by Country (2021-2032)
Figure 66. Turkey Anti-inflammatory Therapeutics Consumption Value (2021-2032) & (USD Million)
Figure 67. Saudi Arabia Anti-inflammatory Therapeutics Consumption Value (2021-2032) & (USD Million)
Figure 68. UAE Anti-inflammatory Therapeutics Consumption Value (2021-2032) & (USD Million)
Figure 69. Anti-inflammatory Therapeutics Market Drivers
Figure 70. Anti-inflammatory Therapeutics Market Restraints
Figure 71. Anti-inflammatory Therapeutics Market Trends
Figure 72. Porters Five Forces Analysis
Figure 73. Anti-inflammatory Therapeutics Industrial Chain
Figure 74. Methodology
Figure 75. Research Process and Data Source
Table 1. Global Anti-inflammatory Therapeutics Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global Anti-inflammatory Therapeutics Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 3. Global Anti-inflammatory Therapeutics Consumption Value by Region (2021-2026) & (USD Million)
Table 4. Global Anti-inflammatory Therapeutics Consumption Value by Region (2027-2032) & (USD Million)
Table 5. AbbVie Company Information, Head Office, and Major Competitors
Table 6. AbbVie Major Business
Table 7. AbbVie Anti-inflammatory Therapeutics Product and Solutions
Table 8. AbbVie Anti-inflammatory Therapeutics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 9. AbbVie Recent Developments and Future Plans
Table 10. Johnson & Johnson Company Information, Head Office, and Major Competitors
Table 11. Johnson & Johnson Major Business
Table 12. Johnson & Johnson Anti-inflammatory Therapeutics Product and Solutions
Table 13. Johnson & Johnson Anti-inflammatory Therapeutics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 14. Johnson & Johnson Recent Developments and Future Plans
Table 15. Amgen Inc Company Information, Head Office, and Major Competitors
Table 16. Amgen Inc Major Business
Table 17. Amgen Inc Anti-inflammatory Therapeutics Product and Solutions
Table 18. Amgen Inc Anti-inflammatory Therapeutics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 19. AstraZeneca PLC Company Information, Head Office, and Major Competitors
Table 20. AstraZeneca PLC Major Business
Table 21. AstraZeneca PLC Anti-inflammatory Therapeutics Product and Solutions
Table 22. AstraZeneca PLC Anti-inflammatory Therapeutics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 23. AstraZeneca PLC Recent Developments and Future Plans
Table 24. Pfizer, Inc Company Information, Head Office, and Major Competitors
Table 25. Pfizer, Inc Major Business
Table 26. Pfizer, Inc Anti-inflammatory Therapeutics Product and Solutions
Table 27. Pfizer, Inc Anti-inflammatory Therapeutics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 28. Pfizer, Inc Recent Developments and Future Plans
Table 29. Novartis Company Information, Head Office, and Major Competitors
Table 30. Novartis Major Business
Table 31. Novartis Anti-inflammatory Therapeutics Product and Solutions
Table 32. Novartis Anti-inflammatory Therapeutics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 33. Novartis Recent Developments and Future Plans
Table 34. Roche Company Information, Head Office, and Major Competitors
Table 35. Roche Major Business
Table 36. Roche Anti-inflammatory Therapeutics Product and Solutions
Table 37. Roche Anti-inflammatory Therapeutics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 38. Roche Recent Developments and Future Plans
Table 39. Merck Company Information, Head Office, and Major Competitors
Table 40. Merck Major Business
Table 41. Merck Anti-inflammatory Therapeutics Product and Solutions
Table 42. Merck Anti-inflammatory Therapeutics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 43. Merck Recent Developments and Future Plans
Table 44. Sanofi Company Information, Head Office, and Major Competitors
Table 45. Sanofi Major Business
Table 46. Sanofi Anti-inflammatory Therapeutics Product and Solutions
Table 47. Sanofi Anti-inflammatory Therapeutics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 48. Sanofi Recent Developments and Future Plans
Table 49. GlaxoSmithKline Company Information, Head Office, and Major Competitors
Table 50. GlaxoSmithKline Major Business
Table 51. GlaxoSmithKline Anti-inflammatory Therapeutics Product and Solutions
Table 52. GlaxoSmithKline Anti-inflammatory Therapeutics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 53. GlaxoSmithKline Recent Developments and Future Plans
Table 54. Sun Pharmaceutical Industries Ltd Company Information, Head Office, and Major Competitors
Table 55. Sun Pharmaceutical Industries Ltd Major Business
Table 56. Sun Pharmaceutical Industries Ltd Anti-inflammatory Therapeutics Product and Solutions
Table 57. Sun Pharmaceutical Industries Ltd Anti-inflammatory Therapeutics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 58. Sun Pharmaceutical Industries Ltd Recent Developments and Future Plans
Table 59. TEVA Company Information, Head Office, and Major Competitors
Table 60. TEVA Major Business
Table 61. TEVA Anti-inflammatory Therapeutics Product and Solutions
Table 62. TEVA Anti-inflammatory Therapeutics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 63. TEVA Recent Developments and Future Plans
Table 64. Global Anti-inflammatory Therapeutics Revenue (USD Million) by Players (2021-2026)
Table 65. Global Anti-inflammatory Therapeutics Revenue Share by Players (2021-2026)
Table 66. Breakdown of Anti-inflammatory Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3)
Table 67. Market Position of Players in Anti-inflammatory Therapeutics, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 68. Head Office of Key Anti-inflammatory Therapeutics Players
Table 69. Anti-inflammatory Therapeutics Market: Company Product Type Footprint
Table 70. Anti-inflammatory Therapeutics Market: Company Product Application Footprint
Table 71. Anti-inflammatory Therapeutics New Market Entrants and Barriers to Market Entry
Table 72. Anti-inflammatory Therapeutics Mergers, Acquisition, Agreements, and Collaborations
Table 73. Global Anti-inflammatory Therapeutics Consumption Value (USD Million) by Type (2021-2026)
Table 74. Global Anti-inflammatory Therapeutics Consumption Value Share by Type (2021-2026)
Table 75. Global Anti-inflammatory Therapeutics Consumption Value Forecast by Type (2027-2032)
Table 76. Global Anti-inflammatory Therapeutics Consumption Value by Application (2021-2026)
Table 77. Global Anti-inflammatory Therapeutics Consumption Value Forecast by Application (2027-2032)
Table 78. North America Anti-inflammatory Therapeutics Consumption Value by Type (2021-2026) & (USD Million)
Table 79. North America Anti-inflammatory Therapeutics Consumption Value by Type (2027-2032) & (USD Million)
Table 80. North America Anti-inflammatory Therapeutics Consumption Value by Application (2021-2026) & (USD Million)
Table 81. North America Anti-inflammatory Therapeutics Consumption Value by Application (2027-2032) & (USD Million)
Table 82. North America Anti-inflammatory Therapeutics Consumption Value by Country (2021-2026) & (USD Million)
Table 83. North America Anti-inflammatory Therapeutics Consumption Value by Country (2027-2032) & (USD Million)
Table 84. Europe Anti-inflammatory Therapeutics Consumption Value by Type (2021-2026) & (USD Million)
Table 85. Europe Anti-inflammatory Therapeutics Consumption Value by Type (2027-2032) & (USD Million)
Table 86. Europe Anti-inflammatory Therapeutics Consumption Value by Application (2021-2026) & (USD Million)
Table 87. Europe Anti-inflammatory Therapeutics Consumption Value by Application (2027-2032) & (USD Million)
Table 88. Europe Anti-inflammatory Therapeutics Consumption Value by Country (2021-2026) & (USD Million)
Table 89. Europe Anti-inflammatory Therapeutics Consumption Value by Country (2027-2032) & (USD Million)
Table 90. Asia-Pacific Anti-inflammatory Therapeutics Consumption Value by Type (2021-2026) & (USD Million)
Table 91. Asia-Pacific Anti-inflammatory Therapeutics Consumption Value by Type (2027-2032) & (USD Million)
Table 92. Asia-Pacific Anti-inflammatory Therapeutics Consumption Value by Application (2021-2026) & (USD Million)
Table 93. Asia-Pacific Anti-inflammatory Therapeutics Consumption Value by Application (2027-2032) & (USD Million)
Table 94. Asia-Pacific Anti-inflammatory Therapeutics Consumption Value by Region (2021-2026) & (USD Million)
Table 95. Asia-Pacific Anti-inflammatory Therapeutics Consumption Value by Region (2027-2032) & (USD Million)
Table 96. South America Anti-inflammatory Therapeutics Consumption Value by Type (2021-2026) & (USD Million)
Table 97. South America Anti-inflammatory Therapeutics Consumption Value by Type (2027-2032) & (USD Million)
Table 98. South America Anti-inflammatory Therapeutics Consumption Value by Application (2021-2026) & (USD Million)
Table 99. South America Anti-inflammatory Therapeutics Consumption Value by Application (2027-2032) & (USD Million)
Table 100. South America Anti-inflammatory Therapeutics Consumption Value by Country (2021-2026) & (USD Million)
Table 101. South America Anti-inflammatory Therapeutics Consumption Value by Country (2027-2032) & (USD Million)
Table 102. Middle East & Africa Anti-inflammatory Therapeutics Consumption Value by Type (2021-2026) & (USD Million)
Table 103. Middle East & Africa Anti-inflammatory Therapeutics Consumption Value by Type (2027-2032) & (USD Million)
Table 104. Middle East & Africa Anti-inflammatory Therapeutics Consumption Value by Application (2021-2026) & (USD Million)
Table 105. Middle East & Africa Anti-inflammatory Therapeutics Consumption Value by Application (2027-2032) & (USD Million)
Table 106. Middle East & Africa Anti-inflammatory Therapeutics Consumption Value by Country (2021-2026) & (USD Million)
Table 107. Middle East & Africa Anti-inflammatory Therapeutics Consumption Value by Country (2027-2032) & (USD Million)
Table 108. Global Key Players of Anti-inflammatory Therapeutics Upstream (Raw Materials)
Table 109. Global Anti-inflammatory Therapeutics Typical Customers
LIST OF FIGURES
Figure 1. Anti-inflammatory Therapeutics Picture
Figure 2. Global Anti-inflammatory Therapeutics Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global Anti-inflammatory Therapeutics Consumption Value Market Share by Type in 2025
Figure 4. Anti-inflammatory Biologics
Figure 5. Non-Steroidal Anti-inflammatory Drugs (NSAIDs)
Figure 6. Corticosteroids
Figure 7. Others
Figure 8. Global Anti-inflammatory Therapeutics Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 9. Anti-inflammatory Therapeutics Consumption Value Market Share by Application in 2025
Figure 10. Arthritis Picture
Figure 11. Respiratory Diseases Picture
Figure 12. Dermatology Picture
Figure 13. Gastroenterology Picture
Figure 14. Others Picture
Figure 15. Global Anti-inflammatory Therapeutics Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 16. Global Anti-inflammatory Therapeutics Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 17. Global Market Anti-inflammatory Therapeutics Consumption Value (USD Million) Comparison by Region (2021 VS 2025 VS 2032)
Figure 18. Global Anti-inflammatory Therapeutics Consumption Value Market Share by Region (2021-2032)
Figure 19. Global Anti-inflammatory Therapeutics Consumption Value Market Share by Region in 2025
Figure 20. North America Anti-inflammatory Therapeutics Consumption Value (2021-2032) & (USD Million)
Figure 21. Europe Anti-inflammatory Therapeutics Consumption Value (2021-2032) & (USD Million)
Figure 22. Asia-Pacific Anti-inflammatory Therapeutics Consumption Value (2021-2032) & (USD Million)
Figure 23. South America Anti-inflammatory Therapeutics Consumption Value (2021-2032) & (USD Million)
Figure 24. Middle East & Africa Anti-inflammatory Therapeutics Consumption Value (2021-2032) & (USD Million)
Figure 25. Company Three Recent Developments and Future Plans
Figure 26. Global Anti-inflammatory Therapeutics Revenue Share by Players in 2025
Figure 27. Anti-inflammatory Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2025
Figure 28. Market Share of Anti-inflammatory Therapeutics by Player Revenue in 2025
Figure 29. Top 3 Anti-inflammatory Therapeutics Players Market Share in 2025
Figure 30. Top 6 Anti-inflammatory Therapeutics Players Market Share in 2025
Figure 31. Global Anti-inflammatory Therapeutics Consumption Value Share by Type (2021-2026)
Figure 32. Global Anti-inflammatory Therapeutics Market Share Forecast by Type (2027-2032)
Figure 33. Global Anti-inflammatory Therapeutics Consumption Value Share by Application (2021-2026)
Figure 34. Global Anti-inflammatory Therapeutics Market Share Forecast by Application (2027-2032)
Figure 35. North America Anti-inflammatory Therapeutics Consumption Value Market Share by Type (2021-2032)
Figure 36. North America Anti-inflammatory Therapeutics Consumption Value Market Share by Application (2021-2032)
Figure 37. North America Anti-inflammatory Therapeutics Consumption Value Market Share by Country (2021-2032)
Figure 38. United States Anti-inflammatory Therapeutics Consumption Value (2021-2032) & (USD Million)
Figure 39. Canada Anti-inflammatory Therapeutics Consumption Value (2021-2032) & (USD Million)
Figure 40. Mexico Anti-inflammatory Therapeutics Consumption Value (2021-2032) & (USD Million)
Figure 41. Europe Anti-inflammatory Therapeutics Consumption Value Market Share by Type (2021-2032)
Figure 42. Europe Anti-inflammatory Therapeutics Consumption Value Market Share by Application (2021-2032)
Figure 43. Europe Anti-inflammatory Therapeutics Consumption Value Market Share by Country (2021-2032)
Figure 44. Germany Anti-inflammatory Therapeutics Consumption Value (2021-2032) & (USD Million)
Figure 45. France Anti-inflammatory Therapeutics Consumption Value (2021-2032) & (USD Million)
Figure 46. United Kingdom Anti-inflammatory Therapeutics Consumption Value (2021-2032) & (USD Million)
Figure 47. Russia Anti-inflammatory Therapeutics Consumption Value (2021-2032) & (USD Million)
Figure 48. Italy Anti-inflammatory Therapeutics Consumption Value (2021-2032) & (USD Million)
Figure 49. Asia-Pacific Anti-inflammatory Therapeutics Consumption Value Market Share by Type (2021-2032)
Figure 50. Asia-Pacific Anti-inflammatory Therapeutics Consumption Value Market Share by Application (2021-2032)
Figure 51. Asia-Pacific Anti-inflammatory Therapeutics Consumption Value Market Share by Region (2021-2032)
Figure 52. China Anti-inflammatory Therapeutics Consumption Value (2021-2032) & (USD Million)
Figure 53. Japan Anti-inflammatory Therapeutics Consumption Value (2021-2032) & (USD Million)
Figure 54. South Korea Anti-inflammatory Therapeutics Consumption Value (2021-2032) & (USD Million)
Figure 55. India Anti-inflammatory Therapeutics Consumption Value (2021-2032) & (USD Million)
Figure 56. Southeast Asia Anti-inflammatory Therapeutics Consumption Value (2021-2032) & (USD Million)
Figure 57. Australia Anti-inflammatory Therapeutics Consumption Value (2021-2032) & (USD Million)
Figure 58. South America Anti-inflammatory Therapeutics Consumption Value Market Share by Type (2021-2032)
Figure 59. South America Anti-inflammatory Therapeutics Consumption Value Market Share by Application (2021-2032)
Figure 60. South America Anti-inflammatory Therapeutics Consumption Value Market Share by Country (2021-2032)
Figure 61. Brazil Anti-inflammatory Therapeutics Consumption Value (2021-2032) & (USD Million)
Figure 62. Argentina Anti-inflammatory Therapeutics Consumption Value (2021-2032) & (USD Million)
Figure 63. Middle East & Africa Anti-inflammatory Therapeutics Consumption Value Market Share by Type (2021-2032)
Figure 64. Middle East & Africa Anti-inflammatory Therapeutics Consumption Value Market Share by Application (2021-2032)
Figure 65. Middle East & Africa Anti-inflammatory Therapeutics Consumption Value Market Share by Country (2021-2032)
Figure 66. Turkey Anti-inflammatory Therapeutics Consumption Value (2021-2032) & (USD Million)
Figure 67. Saudi Arabia Anti-inflammatory Therapeutics Consumption Value (2021-2032) & (USD Million)
Figure 68. UAE Anti-inflammatory Therapeutics Consumption Value (2021-2032) & (USD Million)
Figure 69. Anti-inflammatory Therapeutics Market Drivers
Figure 70. Anti-inflammatory Therapeutics Market Restraints
Figure 71. Anti-inflammatory Therapeutics Market Trends
Figure 72. Porters Five Forces Analysis
Figure 73. Anti-inflammatory Therapeutics Industrial Chain
Figure 74. Methodology
Figure 75. Research Process and Data Source
